Full Breakdown
Target Recalls Up & Up Baby Wipes Over Bacterial Contamination
6/7/2026, 12:33:23 AM
Core Event
Target Corporation announced a voluntary nationwide recall of its private-label Up & Up Fragrance-Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes. The recall follows FDA testing that identified the presence of *Burkholderia cepacia* complex and *Burkholderia gladioli* bacteria in product samples. The agency warned that these organisms can cause “serious and life-threatening infections,” especially in newborns, infants, and other immunocompromised users.
Background & Context
Customers reported discoloration of the wipes and symptoms such as skin irritation, eye irritation, and infections. In response, the U.S. Food and Drug Administration (FDA) collected the complaints, conducted microbiological analysis, and confirmed bacterial contamination. The wipes are manufactured by Turkish supplier Sapro Temizlik Urunleri and sold in Target stores and on Target.com across the United States.
Timeline
- June 5 2026 – FDA issues recall notice and Target posts a public statement.
- Nov 7 2025 – May 5 2026 – Manufacturing date range for the Fragrance-Free wipes.
- Dec 29 – Dec 30 2025 – Manufacturing date range for the Fresh Cucumber wipes.
- 2028 – Expiration dates for all recalled packages (May 10 – Nov 5 for Fragrance-Free; June 29 – June 30 for Fresh Cucumber).
Data & Statistics
- Fragrance-Free: 20-, 72-, 216-, 800-, and 1,200-count packages (UPC 085239265956, 085239265949, 085239265963, 085239266137, 085239266090).
- Fresh Cucumber: 72-, 216-, and 800-count packages (UPC 085239265970, 085239265994, 085239265987).
- Manufacturing codes and expiration dates as listed above.
- The FDA report cites “a number of consumer complaints” but does not provide a specific count.
Why It Matters
*Burkholderia* species can survive in moist environments and are often resistant to multiple antibiotics, complicating treatment. In healthy individuals, exposure may cause only localized skin infections, but in infants or immunocompromised patients the bacteria can enter the bloodstream, leading to sepsis or pneumonia—conditions that can be fatal. The incident also highlights the growing scrutiny of private-label products and the need for rigorous supplier oversight in large retail supply chains.
Official Statements & Responses
- FDA: Emphasized that the wipes are “predominantly used on newborns, infants, and young children, who are particularly vulnerable to opportunistic infection due to their immature immune systems.”
- Target: Stated, “We care deeply about the safety of our guests and our products. Out of an abundance of caution, Target has voluntarily recalled….” The retailer urged customers to stop using the wipes immediately and to return them for a full refund.
- CDC: Noted that “B. cepacia germs can be resistant to antibiotics, making them difficult to treat.”
- The FDA added that the reports remain under investigation.
Criticism & Opposition
Consumer Reports contacted Target for details on the volume and timing of complaints; Target’s response was limited to the generic safety statement. Sapro Temizlik Urunleri did not respond to media inquiries, leaving the manufacturer’s perspective absent from public discourse.
Conflicting Reports & Gaps
No confirmed cases of sepsis or pneumonia have been publicly documented, and the severity of reported infections is still under investigation. The exact number of adverse-event reports remains undisclosed, creating uncertainty about the true scope of the health risk.
Verbatim Quotes
- “Use of products contaminated with Burkholderia cepacia complex and Burkholderia gladioi may result in serious and life-threatening infections,” — U.S. Food and Drug Administration
- “The products are predominantly used on newborns, infants, and young children, who are particularly vulnerable to opportunistic infection due to their immature immune systems.” — FDA written notice
- “In healthy individuals, use of the product on skin with minor lesions will more likely result in local infections, whereas in immunocompromised individuals, newborns, infants and young children, the infection is more likely to spread into the bloodstream, potentially leading to life-threatening sepsis or pneumonia,” — FDA statement
- “B. cepacia germs can be resistant to antibiotics, making them difficult to treat,” — Centers for Disease Control and Prevention
What’s Next
The FDA continues to investigate the source and extent of contamination while monitoring additional consumer reports. Target will honor refunds for all recalled units and has pledged ongoing coordination with Sapro Temizlik Urunleri and regulatory authorities. Consumers are advised to retain packaging, note UPCs and expiration dates, and discontinue use of any affected wipes immediately.
